Struggling Teva Pharmaceutical Plans To Raise $5B In Debt
Generic pharmaceutical giant Teva Pharmaceutical Industries Limited, which is implementing a major cost-cutting campaign intended turn around its business performance, plans to raise $5 billion in new debt, according to a...To view the full article, register now.
Already a subscriber? Click here to view full article